Blood Flow Tissue Articles & Analysis
11 news found
Simon Enzinger, MD, DDS, surgeon at the Department of Oral and Maxillofacial Surgery at the University Hospital Salzburg, used the new instruments on a procedure called a partial glossectomy, where he raised a lateral arm free flap to replace a large section of a patient's tongue which required removal due to cancer. To return blood flow to the transferred ...
The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This intraoperative imaging technology is used in conjunction with the FDA approved indocyanine green (ICG) dye with applications ...
As part of this grant, breast surgeon collaborators will use OnLume’s imaging device for intraoperative visualization and assessment of small lymphatic tissue and blood vessels. The FGS imaging system may help reduce the risk of two breast cancer-related morbidities, lymphedema and tissue necrosis. ...
Alume Bioscience’s CEO and founder Quyen Nguyen, MD/PhD, stated, “As surgeons, we rely on our experience to identify nerves, but often they are buried or appear indistinguishable from adjacent non-nerve tissue. This study aims to demonstrate improvement of surgical precision by making nerves ‘glow’ with fluorescence. ...
The study incorporated the use of the Activ Surgical intraoperative surgical intelligence and the proprietary ActivPerfusion™ visualization mode that allows for dye-free detection and display of tissue perfusion and real-time imperceptible latency. “My peers and I are very pleased with the results of this IRB study using Activ Surgical enhanced visualization,” ...
Sonavex scored FDA clearance for its technology that uses ultrasound imaging and deep learning to deliver blood flow data on demand. The EchoSure system is cleared for use with the company’s EchoMark bioresorbable tissue markers, which got the agency’s nod in June. ...
HemoShear and Takeda are continuing their collaboration under a second agreement established in October 2020 to develop a new human tissue-based model of a rare liver disease using the REVEAL-Tx™ Platform. ...
The new software suite, along with the company’s interoperable imaging module, ActivSight™, are the first commercially-available products of the ActivEdge™ platform, which is being designed to transform massive amounts of data gathered intra-operatively to provide surgeons real-time guidance in the operating room. The ability to detect blood ...
The technology is cleared for fluorescence imaging of blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, reconstructive and microsurgeries. OnLume is developing further applications of its imaging platform, including FGS for cancer surgery in which tumor-specific drugs could deliver ...
HemoShear scientists created in vitro models of MMA and PA to accurately reflect these human disease states by applying principles of physiological blood flow to human tissue from the livers of MMA and PA patients who underwent transplant. ...
Vascuqen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to disease ...